Transcript Highlights:

• Our treatment on page 33 are...
• Our treatment, on page 33, our GR transfer into treatment courts, we have a request to increase the GR
• The discussion then turned to the treatment court NDI.
• for treatment courts because the mental health courts will be within that treatment court structure.
• This was primarily used for Medicaid-assisted treatment within the treatment courts.

Committee: House Budget

Transcript Highlights:

• They provide residential substance use disorder treatment, as well as outpatient treatment, intensive
• </c> offers three residential treatment offers three residential treatment facilities<00:35:08.480><c
• use disorder treatment as well as<00:35:16.960><c> outpatient</c><00:35:17.520><c> treatment,</c><00
• treatment, and medications outpatient treatment, and medications for<00:35:21.520><c> opioid</c><00:
• </c> residential treatment for um I'm sorry. residential treatment for um I'm sorry.

Summary: The meeting opened with a quorum, approval of the September 18, 2025 minutes, and a staff update on recent tobacco settlement-funded agriculture activities. The agriculture side highlighted Commissioner Shell’s outreach, including school visits, farm visits, and speaking engagements in Kentucky and a trip to Tennessee to discuss program models. A representative also described a national conference in Iowa, where Kentucky’s agriculture finance program was praised as a $180 million loan program built with tobacco settlement funds. The board noted September approvals totaling $950,000 for the agriculture development board and $3.3 million for the finance corporation, along with staff activity such as site visits, program closures, and project reports. The board also announced that the KKMP report covering 2015-2022 would be distributed and that the annual report, marking the program’s 25th anniversary, was being prepared. The board then reviewed two featured projects. The Organic Association of Kentucky requested $425,000 for organic producer support, but the board approved only one year of funding at $29,000, with members noting concern about recurring applicants and the need to evaluate long-term funding. The second project, by Joseph Dale Bentley in Lewis County, sought $51,300 to expand a small ruminant facility for goat production and export. Members were particularly interested because the project was already operating and creating market opportunities for Kentucky goat producers; the board approved half the project cost to help expand infrastructure and potentially allow quarantining on site. The cabinet then presented its annual update on tobacco settlement fund use in public health. Julie Brooks, Sarah Johnson, and Andrea Day reported on the HANS home visitation program, tobacco prevention and cessation efforts, lung cancer screening, and early childhood oral health. HANS served more families in FY25, rising from 6,293 to 6,715, and increased services from 139,943 to over 143,000. Tobacco prevention and cessation programs continued to support Quit Now Kentucky and My Life, My Quit, though officials noted federal uncertainty and the loss of federal tobacco control infrastructure. They also reported a slight decline in student outreach and cessation requests, but continued demand from schools and communities for vaping and nicotine prevention support. Lung cancer screening expanded to 55 screens, with Kentucky cited as a model for other states due to improved incidence, survival, and early detection rates. Early oral health efforts continued through local health departments, with more trainings for public health nurses, continued varnish kits, and expanded support for dental graduates and hygiene teams.

Transcript Highlights:

• . technology and treatments to reach more Texans.
• A number of good treatments.
• Some day deliver treatment, some day.
• These devices here, do you mean the actual device or the actual treatment?
• So if I need that treatment.

Bills: HB5 , HJR3 , HB155 , HB513 , HB5 , HB155

Committee: House Public Health

Transcript Highlights:

• <01:08:33.199><c> facility</c> treatment facility treatment facility for<01:08:35.920><c> adjudicated
• In summary, a treatment facility at this In summary, a treatment facility at this high<01:09:51.679><
• </c> mental health residential treatment mental health residential treatment program<01:12:14.560><c>
• </c><01:30:36.239><c> This</c> the treatment needs of a child. This the treatment needs of a child.
• </c> um regarding exempting drug treatment um regarding exempting drug treatment within<01:53:52.800>

Summary: The joint hearing opened with House Bill 1969, which would provide state funding for colorectal cancer screenings for uninsured and underinsured residents. The Department of Human Services said it supports the goal of early screening but would need new administrative capacity, including a program manager and claim pre-screening, to run the program. The Department of Health supported the measure and cited low screening rates in Hawaii, noting an educational campaign to encourage screening. The Insurance Division raised concerns about reliance on federal FAQs, warning that guidance can change and may create state cost exposure. Supporters including the American Cancer Society Cancer Action Network and the Hawaii Medical Association argued the bill would close a preventive-care gap, reduce late-stage diagnoses, and save long-term costs; the committee also discussed implementation costs, estimated by DHS at roughly $1.4 million to $2 million annually plus administrative expenses, and a 6-month to 1-year timeline to establish the program. The committee then took up House Bill 1965, which would require health carriers to spend at least 6% of total medical expenditures on primary care providers. The Insurance Division said several provisions raise technical and legal concerns, including the premium freeze, the medical loss ratio language, the lack of an existing external review process for downcoding claims, and a new mandate for medically necessary inter-island transportation that could trigger an ACA defrayal. The Department of Human Services supported the intent but suggested broader language to include primary care supports and services, and noted that QUEST integration plans already invested at least 9% of total medical expenditures in primary care in 2024, with additional spending on supports and low-value care reductions. State health planning officials strongly supported the bill as an investment in primary care, saying it could improve outcomes and lower long-term costs, though they acknowledged a possible temporary premium increase during the transition. Testimony in support emphasized Hawaii’s physician shortage, especially on Maui, the Big Island, and other neighbor islands, and warned that clinics are under financial strain and may close without higher primary care reimbursement. The Hawaii Healthcare Task Force, AARP Hawaii, and other supporters said the bill would help retain providers, improve access for Medicare and Medicaid patients, and prevent downstream costs from emergency room use and avoidable hospitalizations. No votes or final committee action were taken in the portion of the hearing provided.

Transcript Highlights:

• And finally, you're gonna hear about our treatment courts.
• He's the district treatment court manager for the Fifth District.
• Report home for curfew, complete treatment homework, and recovery step work.
• We focus on treatment and accountability while never losing sight of public safety.
• Treatment courts are a force multiplier in this fight.

Committee: Senate Judiciary and Rules

Transcript Highlights:

• from a provider of the worker's choice and to seek further treatment from a provider of the worker's
• It prohibits an employer from requiring an injured worker to seek treatment from a specific provider
• It allows an injured worker to receive treatment from a provider outside the medical provider network
• when necessary to protect the workers' life or provide additional therapeutic treatment.
• necessary treatment on closed claims and for medical monitoring of cancer patients.

Summary: The committee heard public testimony on several labor-related bills. On Substitute Senate Bill 5874, staff and Senator McEwen described a proposal to let the Employment Security Department waive penalties for minor quarterly reporting errors by employers, especially inadvertent electronic filing issues involving occupational codes and job titles. No one testified in opposition, and the public hearing was closed. The committee then heard extensive testimony on Engrossed Second Substitute Senate Bill 5847, which would expand injured workers’ access to medical providers, allow medically appropriate departures from L&I treatment rules, prohibit employers from requiring treatment from a specific provider, and set timelines for utilization review. Supporters, including workers’ advocates and union representatives, said the bill would improve access to care and reduce delays, while business groups opposed it as weakening the provider network and raised concerns about costs and claim duration. L&I said it could implement the bill with a technical fix and noted that the fiscal note was still being updated. A previously adopted claims-manager staffing amendment was discussed but not included in the version heard. On Engrossed Second Substitute Senate Bill 5061, the committee heard testimony on requiring public works contracts to update prevailing wage rates annually rather than freezing them at bid time. Labor groups supported the bill as protecting workers from wage erosion on long projects, while contractor groups opposed it unless amended to allow change orders for wage increases above 5 percent, citing unpredictable jumps in prevailing wage rates and added risk for small contractors. L&I requested a delayed effective date to July 1, 2028 because of IT changes. The committee also heard testimony on Senate Bill 5944, which would make missed or canceled appointment payments bargained economic compensation for language access providers, and on Substitute Senate Bill 5972, which would extend interest arbitration rights to correctional employees in city and county jails regardless of county population. Labor groups supported both bills; counties and a city representative opposed 5972 over cost concerns and asked for fiscal safeguards. Finally, the committee heard Engrossed Substitute Senate Bill 6302, which would require L&I to investigate possible misclassification when three or more independent contractors are used for the same type of finishing work on a public works project. Labor and contractor groups both supported the amended version, saying it targets misclassification without banning legitimate independent contractors. The hearing ended after testimony, with no votes or final committee actions taken during the meeting.

Transcript Highlights:

• And we have even seen patients who require methadone treatment for their dependence.
• She required treatment with buprenorphine for her withdrawal symptoms.
• She required treatment with buprenorphine for her withdrawal symptoms.
• I heard people talk about using it as a pain treatment as well.
• This product is not intended to be used or sold for the treatment substance.

Summary: The committee held an informational hearing on kratom and 7-hydroxymitragynine (7-OH), focusing on public health risks, overdose deaths, and regulatory gaps in California. The chair opened by noting that FDA and CDPH consider kratom and 7-OH products unlawful, yet they remain widely sold in smoke shops, vape stores, gas stations, and convenience stores. Members referenced AB 1088, which would be considered later, and said the hearing was intended to clarify the science, medical perspective, and whether stronger safeguards are needed. The first panel featured a toxicology expert, state and local public health officials, an emergency/addiction physician, a medical examiner, and county health representatives. Witnesses from CDPH and Los Angeles County described rising deaths and enforcement actions, including statewide advisories, retailer letters, and product removals from manufacturers, wholesalers, and retailers. Medical testimony emphasized that 7-OH acts much more like an opioid than traditional kratom leaf, can cause dependence, withdrawal, and respiratory depression, and may require naloxone, buprenorphine, or methadone in overdose or withdrawal cases. Local officials said enforcement is difficult because packaging is inconsistent, testing capacity is limited, and counties lack resources and statewide infrastructure; they generally favored a centralized state framework if regulation is pursued. Committee members asked about testing, age restrictions, scheduling, and whether a distinction between kratom and 7-OH could be enforced. Witnesses said forensic labs can potentially test for 7-OH but validated assays are not routine, emergency departments cannot readily distinguish exposures, and local health departments do not have the lab capacity to verify product labels. Several officials warned that a ban or abrupt scheduling could push products into the black market and discourage research, while others argued that current prohibition and enforcement are the most protective approach because legalization or age-limited regulation could create confusion about legality and safety. The second panel included kratom and 7-OH advocates and industry representatives, who argued that natural kratom leaf and concentrated or synthetic 7-OH are different products and should be regulated differently. They supported age-gating, labeling, testing, and packaging rules for kratom leaf while opposing a ban on the botanical. They said 7-OH is used by many adults for pain relief or harm reduction, and that prohibition would drive consumers to illicit markets and worsen harm. Committee members pressed them on whether 7-OH is more potent than kratom, the availability of testing, and whether any safe dose is known. The hearing ended without a vote or formal action, with the chair noting the issue will continue to be considered in future legislation.

Transcript Highlights:

• But in the literature, I have a fear of patients not getting adequate treatment.
• I'm thriving, and I feel like people should have access, easy access, to these treatments.
• but But You know, the state and how many have viewed this type of treatment.
• Without treatment, babies have a 100% mortality rate before their first birthday.
• Without treatment, babies, it's 100% mortality rate before their first birthday.

Bills: S0688 , S1414 , S0186 , S0902 , S0196 , S1574 , S0878 , S1092 , S1032 , S1684 , S1686 , S1760

Committee: Senate Health Policy

Summary: The committee took up several health-related bills and confirmations. It first heard SB 1414 on congenital cytomegalovirus education, which would require the Department of Health to develop and distribute educational materials to expectant and new parents through maternity, prenatal, newborn, and OB-GYN settings; an amendment removed a section on required instruction for medical professionals, and the bill was reported favorably as a committee substitute. The committee then approved a block of appointees on tabs 2 through 7 and separately confirmed Chavon Harris as Secretary of the Agency for Health Care Administration after her testimony on Medicaid accountability, transparency, managed care oversight, rural health, behavioral health, and the state’s technology modernization efforts. Senators asked Harris about Hope Florida, Medicaid redeterminations, the CORE project, an anti-marijuana ad campaign at DCF, and compliance with a federal Medicaid-related court order; she said she would follow up on some issues. The confirmation was recommended favorably, with Senator Berman voting no. The committee next passed SB 186 on student health and safety, which expands epilepsy and seizure-disorder training requirements to more school personnel, including bus drivers and charter school staff, and requires seizure-first-aid posters and updated Department of Health education efforts. It also approved SB 902 on Department of Health issues after amendments narrowed the bill’s scope and added provisions on medical marijuana regulation, early childhood intervention, practitioner accountability, and autism workforce development; one speaker raised concerns about marijuana dispensary location restrictions and low-THC ratios. SB 196 creating a uterine fibroid research database was also reported favorably after an amendment protecting patient privacy; the bill drew emotional testimony from a patient describing severe symptoms and the need for more research. SB 688 on naturopathic medicine was approved after committee discussion about scope of practice, referral obligations, and whether naturopathic care should be adjunctive to conventional medicine; supporters described complementary care and access issues, while opponents worried about delayed treatment for serious disease. Later, the committee passed SB 1574, “Maddie’s Law,” to add biliary atresia screening to newborn screening using the same blood specimen already collected at birth and to launch an education campaign; parents of a child affected by the disease testified that earlier screening could have prevented severe harm. SB 878 on clinical laboratory personnel was reported favorably to address staffing shortages by allowing Florida to rely more directly on federal CLIA standards for qualified lab workers. SB 1092 on podiatric medicine was approved after an amendment narrowed it to cellular/tissue-based products and podiatrists’ use of certain therapies; the bill also addresses continuing education, informed consent, and advertising disclosures. SB 1032 on medical marijuana was amended and passed, aligning physician certification and card renewal timelines, setting 70-day and 35-day supply limits, and reducing the fee for honorably discharged veterans while preserving funding for FAMU; Senator Harrell opposed it, saying the longer timeframes were too much of an expansion. The committee also heard SB 1760 on Medicaid coverage transparency from Senator Brodeur, who said the bill focuses on accountability and fiscal responsibility, but the transcript cuts off before further discussion or action on that measure.

Transcript Highlights:

• But in the literature, I have a fear of patients not getting adequate treatment.
• But in the literature, I have a fear of patients not getting adequate treatment.
• I'm thriving, and I feel like people should have access, easy access to these treatments.
• but But You know, the state and how many have viewed this type of treatment.
• Without treatment, babies have a 100% mortality rate before their first birthday.

Committee: Senate Health Policy

Transcript Highlights:

• </c><00:08:05.720><c> more</c> Services making cancer treatment more Services making cancer treatment
• of $90,000 for a 12-week treatment.
• of $90,000 for a 12-week treatment.
• </c><00:15:06.399><c> while</c> $90,000 for a 12we treatment while $90,000 for a 12we treatment while
• ><c> also</c> treatment is expensive it's also treatment is expensive it's also effective<00:15:09.480

Summary: The Senate Standing Committee on Health Services opened with the chair welcoming several new members and outlining session rules: hearings would start and end on time, the committee would limit the number of bills heard each meeting, prioritize bills heard during the interim, and generally avoid using the consent calendar except in extreme circumstances. The committee then briefly considered administrative regulations, which were treated as approved if members had no questions. The main item was Senate Bill 14, a measure addressing the 340B drug discount program. The chair said the bill had already passed the Senate in a prior session and had been heard in interim, so he did not present it again. He described the bill as prohibiting drug manufacturers from discriminating against 340B covered entities by refusing 340B pricing when the same drug is offered at that price in the state. He also said the committee would not debate the federal 340B program itself, but would hear testimony on the bill. Hospital leaders and Kentucky Hospital Association representatives testified in support, arguing that 340B savings are essential to rural hospitals, oncology services, transportation support, chronic care, addiction recovery, and new service lines such as chemotherapy and hepatitis treatment. They said the program helps keep care close to home and that manufacturer restrictions on contract pharmacies have reduced access and cost hospitals millions. Opponents from BIO Kentucky and the National Alliance of Healthcare Purchaser Coalitions argued the bill would expand federal law beyond Congress’s intent, create administrative burdens, and not lower patient out-of-pocket costs. The chair repeatedly pressed opponents to address why Kentucky should be denied the same 340B pricing available in other states. No vote on the bill was taken in the portion provided.

Transcript Highlights:

• As of July 1, Idaho had 30 licensed facilities, Treatment.
• So our research identified a treatment oversight gap.
• So in Idaho, no one has oversight treatment within children's residential care.
• So our research identified a treatment oversight gap. or is working.
• And that has their own special requirements and oversight for treatment.

Transcript Highlights:

• That treatment plant had not been functioning for probably 15 years.
• I just want to make a very clear point that neither the treatment plant on the U.S. side nor the treatment
• That treatment plant had not been functioning for probably 15 years.
• treatment plan on the Mexican side is treating anything flowing.
• plant, are not removed by the sewage treatment process.

Summary: The joint Senate and Assembly Environmental Quality/Environmental Safety and Toxic Materials informational hearing focused on the Tijuana River Valley sewage crisis, with members from both parties emphasizing that the problem is long-running, cross-border, and severe enough to require federal, state, local, and binational action. Opening remarks described the crisis as an environmental and public health emergency affecting beaches, air and water quality, marine life, tourism, and residents’ quality of life in South Bay communities. Assembly Member Boerner and Senator Jones both stressed the need for continued funding and cooperation, while Senator Padilla said the issue is underappreciated because of where it occurs but has major public health, economic, and educational consequences. Congressman Mike Levin’s office reported more than $650 million in federal funding secured for infrastructure and cleanup, along with federal legislation and requests for CDC and EPA involvement. Supervisor Paloma Aguirre gave a detailed overview of county efforts and the scope of the crisis, citing decades of sewage flows from Tijuana, nearly four years of beach closures, and the county’s expanded water-quality monitoring. She said the county is pursuing warning signs, an air purifier distribution program, an epidemiological study, soil testing, an economic impact study, and a feasibility analysis to remove the “hot spot” near Saturn Boulevard, which she described as a key local source of airborne pollution. She also pointed to binational funding for treatment plant upgrades and said the county is seeking state support, including from Proposition 4 cross-border river funds, to expand relief and mitigation efforts. Scripps researchers Dr. Sarah Giddings and Dr. Kimberly Prather presented scientific findings on water and air transport. Giddings described a high-resolution forecast model that predicts wastewater movement and beach closure risk up to five days ahead, using real-time observations and showing about 72% accuracy against county measurements. Prather said the main exposure route is through air, not just water, and reported that turbulence at the river hot spot aerosolizes pollutants, with hydrogen sulfide and other gases spiking at night and dropping when river flow is diverted. She said the team has identified thousands of gases and linked measurements closely to odor complaints, while also noting that air purifiers can reduce indoor exposure but are not a permanent solution. Dr. Paula Stigler Granados added that community health surveys and CDC assessments show widespread symptoms, sleep disruption, anxiety, and daily life impacts, especially during nighttime odor events. She said her team has found more than 900 contaminants in river water and 106 chemicals uniquely associated with the Saturn Boulevard hot spot, with passive air sampling showing similar chemical fingerprints in nearby homes. The panel discussion ended with questions about standards and accountability, and witnesses and legislators agreed that the crisis requires updated air-quality standards, more health research, and continued coordination to reduce exposure and address the source of pollution.

Transcript Highlights:

• </c><01:20:02.560><c> with</c> unresponsive uh treatment with unresponsive uh treatment with depression
• </c> this bill um starting with treatment this bill um starting with treatment resistant<01:32:42.480
• </c> that do show positive treatment that do show positive treatment response. response. response.
• </c> treatment. That's actually incorrect. treatment. That's actually incorrect.
• </c> have um an alternative treatment have um an alternative treatment facility<01:46:06.400><c> that

Committee: Senate Health and Human Services

Transcript Highlights:

• treatment plan, but it may get us to the same point.
• My treatment plan is better than this person's treatment plan, but it may get us to the same point, okay
• But the delta between prevention and treatment is very small.
• I suspect in 2025 we are going to see an uptick in treatment.
• Care and treatment.

Summary: The Care Management Meeting opened with a DSS update on the PCMH program. Staff reported the program remained steady at 124 practices, 553 sites, and 2,548 providers, with some month-to-month fluctuation driven by practice consolidation, retirements, and a few practices leaving the program because NCQA requirements were burdensome. Members asked about declining provider and site counts, member attribution trends, and whether PCMH practices overlap with behavioral health homes; DSS said attribution changes are largely due to members becoming ineligible, moving, or getting other insurance, and that PCMH and behavioral health homes are separate programs that coordinate informally. The committee also discussed why some smaller practices leave the program and whether the requirements could be made easier to support retention. The committee then resumed a detailed presentation on the Husky Dental program. The presenter described the dental benefit’s history, the importance of preventive oral health, workforce and consolidation pressures in dentistry, and the lack of interoperability between dental and medical records. Network data showed year-over-year declines in enrolled dental practitioners and service locations, with access gaps concentrated in rural and eastern parts of the state. Appointment availability surveys showed average waits of 38 days for adults and 23 days for children, but much longer waits at FQHCs than private fee-for-service practices. The presenter said Connecticut remains above the national median on CMS pediatric dental quality measures, though sealant rates remain a concern, and noted that preventive care is associated with lower per-member costs. Members raised concerns about provider participation, large practices dropping Medicaid, mobile dental care, and whether the public directory accurately reflects which dentists are actually accepting new patients. The presenter said the plan uses secret-shopper calls, tracks appointment availability, and has begun using place-of-service coding to better identify school-based dental care. She also noted a new MOU with 20 Head Start programs to share data and provide oral health literacy and navigation support. The final major topic was implementation planning for HR1. DSS said CMS guidance was expected in early June and proposed using upcoming meetings to cover medical frailty, communication strategy, and data integration/ex parte verification. Committee members urged the department to create a dashboard to track disenrollments and other impacts of HR1, to build a process for complaints and problem resolution, and to think through cost-sharing, caregiver verification, exemptions, and notices. Members also asked about using existing eligibility structures such as the working-disabled program as a model. The committee agreed to move the next meeting to June 10 by Zoom, with the agenda to be circulated in advance and any PCMH Plus quality data shared if available.

Transcript Highlights:

• ><c> treatments</c><00:33:19.320><c> are</c><00:33:19.440><c> very</c> everywhere their treatments are
• to be established treatments.
• to be established treatments.
• to be established treatments.
• to be established treatments.

Committee: Senate Transportation

Transcript Highlights:

• So treatment works. There's a journey to get to it, but treatment works.
• So treatment works. effectiveness rate. So treatment works.
• </c> treatment works. treatment works.
• Treatment first and treatment first.
• So, and they have state-supported treatment. They have private treatment.

Bills: HB1952 , HB1951 , HB1929 , HB2497 , HB2208 , HB2572 , HB1953 , HB2551 , HB2549 , HB1737 , HB1628 , HB1769 , HB2493 , HB2264 , HB1997 , HB2168 , HB2427 , HB1805 , HB2180 , HB2184 , HB2219 , HB2469 , HB2233 , HB2519 , HB2141 , HB1904 , HB2201 , HB2410 , HB2007 , HB2385 , HB2444 , HB2349 , HB2235 , HB1872 , HB2416 , HB2291 , HB2292 , HB2263 , HB2359 , HB2455 , HB1509 , HB1514 , HB1515 , HB1648 , HB2164 , HB2323 , HB1825 , HB2172 , HB1888 , HB2005 , HB2387 , HB2358 , HB2119 , HB2276 , HB2472 , HB1714 , HB2325 , HB1541 , HB1960 , HB2140 , HB2315 , HB2367 , HB2388 , HB1696 , HB2333 , HB2138 , HB2332 , HB2283 , HB2059 , HB2057 , HB2589 , HB2417 , HB2337 , HB1588 , HB2217 , HB2020 , HB1915 , HB1742 , HB2026 , HB1965 , HB1546 , HB2360 , HB1563 , HB1749 , HB2614 , HB1511 , HB1753 , HB1849 , HB1641 , HB2161 , HB2194 , HB1721 , HB2284 , HB2188 , HB1897 , HB1880 , HB1573 , HB1876 , HB20 , HB2137

Transcript Highlights:

• Last but not least, substance use disorder treatment and prevention.
• Madam Chair, regarding the Injectable Opioid Treatment Program, Dr.
• Treatment per se.
• And then they can be extended or not, the treatment.
• Excuse me, fallback plan to sustain treatments and recovery treatment and harm reduction services.

Committee: House Legislative Health & Human Services Committee

Transcript Highlights:

• It enables hyperbaric oxygen treatment therapy to be allowed in assisted living facilities.
• I cannot support expanding optional medical treatments in these facilities. I vote no.
• Petitioning for involuntary treatment was necessary.
• Petitioning for involuntary treatment was necessary, but it was also traumatic.
• Court-ordered treatment is medical care, not punishment.

Committee: Senate Senate Health and Human Services COR

Summary: The committee heard a series of bills and public testimony, beginning with introductions and then taking up several health and human services measures. A major focus was SB 1120 and SB 1121, which address radiation protection in cardiac catheterization and other ionizing-radiation procedure rooms. SB 1120 would require health care facilities to equip at least 50% of procedure rooms with radiation protection systems by July 1, 2027, while SB 1121 would prohibit requiring lead aprons in rooms with such systems and instead require real-time dosimeters for staff who opt out of lead aprons. Physicians, nurses, and a hospital executive testified that enhanced radiation protection systems can dramatically reduce occupational exposure, lower cancer and orthopedic risks, and help with workforce recruitment and retention; a hospital alliance remained neutral pending further stakeholder discussions. Both bills were amended and passed out of committee on 7-0 votes, and SB 1118, which appropriates state funds for a rural hospital grant program to install radiation protection systems, also passed 7-0. The committee also approved SB 1001, which appropriates $1 million to the Department of Economic Security for the Older Individuals Who Are Blind program, after testimony from blind and low-vision Arizonans and advocates describing long waitlists, the need for independent living training, and the program’s role in preventing unnecessary dependence. SB 1072, a major funding bill for home- and community-based services and room-and-board rate increases for individuals with intellectual and developmental disabilities, drew testimony from providers about severe staffing shortages, overtime, turnover, and underfunding; it passed 6-0 with one not voting. SB 1125, requiring DCS to pursue MOUs with tribes and improve tribal communication and access to licensing and enforcement information, also passed 6-0 with one not voting. The committee then considered SB 1123, which removes a board-certification requirement so trained forensic pathologists can supervise autopsy training for residents and fellows; Maricopa County supported it as a workforce and training fix, and it passed 6-0 with one not voting. SB 1052, allowing mild hyperbaric oxygen therapy in assisted living facilities under physician order and DHS rules, generated mixed testimony: supporters argued it could improve health and independence for residents, while opponents raised concerns about off-label treatment in nonmedical settings. The bill passed 5-2. SB 1112, which reduces the number of acquaintance witnesses required in court-ordered treatment proceedings from two to one and allows the court to waive the witness requirement under certain conditions, drew strong testimony from families and mental health advocates on both sides; it passed 5-2. The committee also began hearing SB 1113, which would allow certain service of process in court-ordered evaluation and treatment cases by evaluation-agency employees or other court-authorized persons, but the transcript cuts off before final action on that bill.

Transcript Highlights:

• treatment protocol would be and the appropriate storage time.
• the treatment protocol would be whatever the treatment protocol would be and<00:49:36.640><c> the</c
• This is actually treatment for the patient they’re requesting.
• I was diagnosed with multiple treatment.
• This is also a treatment that could benefit her.

Bills: HB0028 , HB0080

Committee: Senate Labor, Health & Social Services

Transcript Highlights:

• CAN WE HAVE THE INDIANS LISTEN TO OUR TREATMENT VISIT.
• HOW DO YOU SEE CAN BE USED FOR MAKING TREATMENT DECISIONS OR DO YOU?
• HOW DO YOU SEE CAN BE USED FOR MAKING TREATMENT DECISIONS OR DO YOU?
• OBVIOUSLY WE WANT TO UNDERSTAND TREATMENT OPTIONS AND THERE MAY BE AN AREA THAT THERE IS A BETTER TREATMENT
• BOTH FROM THE INSURANCE SIDE AS THE TREATMENT CENTER OUTSIDE.